The Valley Desk

NCT05667493 · Interventional trial

An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

Overall registry status Enrolling by invitation

Phase 3

Conditions Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov